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Background: Smaller nanoparticles facilitate the delivery of DNA into cells through   endocytosis 
and improve transfection efficiency. The aim of this study was to determine whether protamine 
sulfate-coated calcium phosphate (PS-CaP) could stabilize particle size and enhance transfection 
efficiency.
Methods: pEGFP-C1 green fluorescence protein was employed as an indicator of transfection 
efficiency. Atomic force microscopy was used to evaluate the morphology and the size of the 
particles, and an MTT assay was introduced to detect cell viability and inhibition. The classical 
calcium phosphate method was used as the control.
Results: Atomic force microscopy images showed that the PS-CaP were much smaller than 
classical calcium phosphate particles. In 293 FT, HEK 293, and NIH 3T3 cells, the   transfection 
efficiency of PS-CaP was higher than for the classical calcium phosphate particles. The difference 
in efficiencies implies that the smaller nanoparticles may promote the delivery of DNA into 
cells through endocytosis and could improve transfection efficiency. In addition, PS-CaP could 
be used to transfect HEK 293 cells after one week of storage at 4°C with a lesser extent of 
efficiency loss compared with classical calcium phosphate, indicating that protamine sulfate 
may increase the stability of calcium phosphate nanoparticles. The cell viability inhibition assay 
indicated that both nanoparticles show similar low cell toxicity.
Conclusion: PS-CaP can be used as a better nonviral transfection vector compared with 
  classical calcium phosphate.
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Introduction
Calcium phosphate is one of the widely used nonviral vectors for in vitro transfection 
of a variety of mammalian cells due to its low toxicity, biodegradability, ease of use, 
and adsorptive capacity for pDNA.1–4 However, the transfection efficiency of the 
  classical calcium phosphate method strongly depends on preparation parameters, such 
as pH, concentrations of calcium chloride and DNA, temperature, the time between 
precipitation and transfection, cell types, as well as the skills of the researcher.4–6 
Thus, the reproducibility of this method is poor compared with other transfection 
methods based on liposomes and polymers, and has to be optimized for every cell 
line and laboratory.1,7 Furthermore, calcium phosphate particles grow with time, and 
consequently, its transfection efficiency is reduced.1
The size of calcium phosphate particles greatly affects their transfection efficiency.8 
Many efforts have been made to prepare calcium phosphate particles with appropriate 
sizes, including the preparation of calcium phosphate nanoparticles to facilitate International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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delivery of DNA into cells through endocytosis and thereby 
improve transfection reproducibility and efficiency.9 Olton 
et al reported a novel method to improve the manufacture 
of the calcium phosphate precipitate by optimizing both the 
stoichiometry (Ca/P ratio) of the calcium phosphate particles, 
as well as the mode by which the calcium and phosphate 
precursor solutions are mixed.10 Additionally, maximum 
transfection efficiencies in both HeLa and MC3T3-E1 cell 
lines have been obtained when the synthesized particles used 
were within the optimum Ca/P ratio between 100 and 300, 
and with sizes between 25 and 50 nm. Bisht et al and Roy et al 
condensed DNA in a reverse microemulsion environment 
to prepare calcium phosphate nanoparticles 100–120 nm 
in diameter.11,12 The in vitro transfection efficiency of these 
calcium phosphate nanoparticles was found to be higher 
than that of the commercial transfection reagent, Polyfect®. 
However, these particles aggregated rapidly with time.
Functionalization by organic molecules was therefore 
used to preserve the small size of the calcium phosphate 
particles and to inhibit their further growth. A novel calcium 
phosphate nanoparticle formulation was developed by 
rapid precipitation, followed by immediate adsorption of 
DNA, which also stabilizes calcium phosphate colloids. 
The DNA-coated calcium phosphate nanoparticles 
were 10–20 nm in diameter, showed good transfection 
efficiency, and could be stored for weeks without loss of 
their transfection activity.7,8,13,14 Moreover, the efficiency 
of the multishell particles is significantly higher than that 
of simple DNA-coated calcium phosphate nanoparticles.1 
A lipid-coated calcium phosphate nanoparticle formulation 
was developed for systemic siRNA and gene delivery.9 
Kakizawa et al prepared nanoparticles consisting of calcium 
phosphate, DNA, and block copolymers. Small particle sizes 
and good colloidal stability were achieved by the steric 
effect of a polyethylene glycol layer surrounding the calcium 
phosphate core.15,16 Liu et al reported the in vitro preparation 
of 24–35 nm calcium phosphate nanoparticles coated with 
bovine serum albumin as a DNA vector.17 Chowdhury et al 
successfully constructed nanohybrids of DNA/calcium 
phosphate particles with extracellular matrix proteins (either 
collagen 1 or fibronectin), leading to remarkably high 
transgenic expression in mammalian cells.18
Cationic cell-penetrating peptides have been shown to 
deliver a wide variety of cargo into primary cells and most 
tissues in preclinical models.19 Protamine sulfate is a 5 kDa 
cationic peptide rich in arginine that is similar to cationic 
cell-penetrating peptides.20 In the present study, considering 
that the adsorption of protamine sulfate onto the surface 
of the DNA/calcium phosphate particles may stabilize 
particle size and further inhibit growth, we have developed 
a novel protamine sulfate-modified calcium phosphate 
  nanoparticle formulation (PS-CaP) for efficient delivery of 
DNA into cells.
Materials and methods
Materials
All chemicals and cell culture media used in these 
experiments were purchased as follows: analytical protamine 
sulfate (99.0%) from Sigma Aldrich (St Louis, MO), other 
compounds of analytical grade from Shanghai Songon, 
China, and Dulbecco’s minimum essential medium (DMEM) 
and penicillin/streptomycin from Invitrogen. The three cell 
lines used in these experiments, namely, 293 FT, HEK 293, 
and NIH 3T3 cells, were obtained from the American Type 
Culture Collection (Rockville, MD).
Synthesis of pDNA-loaded classical 
calcium phosphate and PS-CaP
The pDNA-loaded classical calcium phosphate was 
synthesized according to the methods reported in the 
literature,3,4 as follows: protamine sulfate was dissolved in 
steaming water up to concentrations of 1%, 2%, and 4%, 
and then pH was adjusted to 7.0. Solution 1 was obtained by 
2 × HEPES-buffered saline and protamine sulfate solution 
mixed at a volume ratio of 1:1. pEGFP-C1 green fluorescence 
protein was incubated with 0.25 M of calcium chloride for 
five minutes and was then added to solution 1 on a vortex at 
a rate of about 1 drop/sec. The classical calcium phosphate 
particles and PS-CaP particles were designated as 0PS-CaP, 
1PS-CaP, 2PS-CaP, and 4PS-CaP with 0%, 1%, 2%, and 
4% protamine sulfate concentrations, respectively. After 
different periods of storage at 4°C, the complexes were used 
for transfection.
Atomic force microscopy
A Nanoscope IIIa controller with a multimode atomic force 
microscope (Digital Instruments, Santa Barbara, CA) was 
used for imaging. Atomic force microscopic images were 
taken in air under tapping mode with standard 125 mm 
single-crystal silicon cantilevers (Model TESP, Digital 
Instruments). All images shown here are height images.
In vitro transfection studies using 293 FT, 
heK 293, and NIh 3T3 cells
The 293 FT, HEK 293, and NIH 3T3 cell lines were cul-
tured in 10% fetal calf serum/DMEM supplemented with International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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100 IU/mL penicillin and 100 µg/mL streptomycin under a 
humidified atmosphere at 37°C and 5% CO2. The cells were 
maintained at subconfluence and passaged every 2–3 days. 
The cells were then seeded into 24-well cell culture plates 
at a cell concentration of 1.63 × 105 cell/well a day before 
transfection so that a cell confluence of approximately 70% 
could be obtained just prior to transfection. The resulting 
transfection mixtures were then immediately added to the 
wells (50 µL/well) in a dropwise manner. The PS-CaP 
particles and classical calcium phosphate particles were 
allowed to remain in the cell culture medium for 4–6 hours, 
after which the cell culture medium was replaced with fresh 
serum medium, and the cells were allowed to incubate for 
another 24 hours. At 24 hours post-transfection, the trans-
fection result of the reporter gene selected, pEGFP-C1, was 
observed under confocal fluorescence microscopy (Radiance 
2100, Zeiss).
MTT assay
HEK 293 cells were harvested during the logarithmic 
growth phase and then seeded into 24-well plates (Corning 
Glassworks, Corning, NY) at a density of 1.5 × 104 cells/mL 
in a final volume of 500 µL/well. The cells were grown to 
90% confluence and were then treated with the PS-CaP and 
classical calcium phosphate particles using a series of dosages 
in low serum for a further 24 hours. Then, 50 µL of 3-(4.5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT, Sigma Aldrich) solution (5 mg/mL in phosphate-
buffered saline) was added to each well for an additional 
four hours. Dark blue formazan crystals were formed in the 
intact cells. The supernatant was removed, and the crystals 
were solubilized with 100 µL dimethylsulfoxide (Sigma 
Aldrich). Cell viability was determined by a conventional 
MTT reduction assay. This assay is based on the reduction of 
MTT into formazan, which provides a sensitive measurement 
of the normal metabolic status of cells. The extent of MTT 
reduction was measured using a Model 680 microplate 
reader (Bio-Rad, Bath, UK) at 570 nm. The experiments 
were performed at least three times.
Flow cytometry analysis
The fluorescence intensity of the pEGFP-C1 green fluo-
rescence protein after transgenic expression was measured 
by flow cytometry. The cells were gently harvested using 
0.2% trypsin-ethylenediamine tetra-acetic acid solution 
at 24 hours post-transfection, washed twice with 3 mL 
phosphate-buffered saline, and 1 × 104 events were analyzed 
on a flow cytometer equipped with a 488 nm excitation laser 
wavelength operated at 450 V . The untransfected cells were 
gated as a population in M1 on a flow cytometry histogram, 
and the transfected cells were gated as a population in 
M2. The transfection efficiencies of the pEGFP-C1 green 
fluorescence protein were estimated at the percentage of 
M2/(M1 + M2).
statistical analysis
Statistically significant differences between the control 
and treatment groups were determined by the Student’s 
t-test. The accepted level of significance was P , 0.05. 
All experiments were conducted in triplicate with separate 
independent cultures.
Results
size and morphology of calcium 
phosphate particles
The size and morphology of the calcium phosphate par-
ticles were measured using atomic force microscopy. 
Figure 1 shows the atomic force microscopic images for 
the 0PS-CaP and the 1PS-CaP after storage for two hours 
and seven days at 4°C, respectively. Nanoparticles with 
nearly spherical morphology were observed. The atomic 
force microscopic images also revealed that the 1PS-CaP 
were much smaller than the 0PS-CaP after different storage 
periods at 4°C. The primary sizes of the 1PS-CaP and the 
0PS-CaP were approximately 30 nm and 150 nm after   storage 
for two hours, respectively. After storage for seven days, 
the sizes of both grew to approximately 100 nm and 500 nm, 
respectively.
In vitro transfection studies in mammalian 
cell lines
In vitro transfection of the NIH 3T3, 293 FT, and HEK 
293 cells with the pEGFP-C1 green fluorescence protein 
encapsulated in the 1PS-CaP, 2PS-CaP, 4PS-CaP, and 
0PS-CaP was observed using laser fluorescence confocal 
microscopy. pEGFP-C1 green fluorescence protein was 
used as an indicator of transfection efficiency, and the 
classical calcium phosphate method was used as the control. 
As shown in Figures 2 and 3, as well as in the Table 1, the 
protamine sulfate-modified particles show significantly 
higher transfection efficiency than the 0PS-CaP for 
the three cell lines. Furthermore, their transfection 
efficiencies were enhanced with increasing protamine sulfate 
concentrations.
To determine further the effects of protamine modification 
on the in vitro transfection of mammalian cells, the 1PS-CaP, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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2PS-CaP, 4PS-CaP, and 0PS-CaP were used for transfection 
of HEK 293 cells after they were left to stand for two hours and 
for seven days. As shown in Figure 3 and in the Table, there 
was some decrease in their transfection efficiencies. After 
standing for seven days, the pEGFP-C1 green fluorescence 
of the 0PS-CaP for transfection of HEK 293 significantly 
declined, whereas the protamine sulfate-modified particles 
remained with higher transfection efficiencies.
cytotoxicity assay
Given that this present work aimed to use the PS-CaP 
particles as gene delivery carriers, their cytotoxicity was 
considered. Figure 4 shows the effect of the PS-CaP and 0PS-
CaP dosage on cell viability, as detected by MTT assay. Cell 
viability decreased with increasing dosage in HEK 293 cells. 
However, their MTT values did not decline significantly 
and were not distinctly different. In addition, the results of 
the statistical analyses show that the difference between the 
control (0PS-CaP) and treatment groups (PS-CaP) was not 
significant at the 0.05 level except for 1PS-CaP and 0PS-CaP 
at the 50 µL dosage (P , 0.05). These results indicate that 
PS-CaP have low cytotoxicity like 0PS-CaP when near the 
transfection dosage.
Discussion
The search for efficient and safe carriers to deliver genes 
into cells remains a great challenge in gene therapy. 
Inorganic nanoparticles are especially suitable for this 
purpose because they can be surface-functionalized in many 
different ways, and thus show good biocompatibility and 
potential for targeted delivery. Furthermore, nanoparticles 
can penetrate the cell wall via endocytosis and deliver genes 
or biomolecules into living systems, usually for therapeutic 
purposes. Many inorganic nanoparticles, such as calcium 
phosphate, gold, carbon materials, silicon oxide, iron oxide, 
and layered double hydroxide, have been studied for gene 
delivery.21,22 Among these nonviral gene delivery vectors, the 
coprecipitation of calcium phosphate with pDNA remains 
an attractive option due to the good biocompatibility and 
biodegradability of calcium phosphate.10
The particle size of calcium phosphate significantly 
affects transfection efficiency.8 However, calcium phosphate 
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Figure 1 Representative atomic force microscopic images of the classical calcium phosphate particle (0PS-CaP) and protamine sulfate-coated calcium phosphate particle 
(1PS-CaP) after standing for two hours and seven days, respectively. 
Abbreviations: PS-CaP, protamine sulfate coated-calcium phosphate; 0PS-CaP, PS-CAP with 0% protamine sulfate concentration; 1PS-CaP, PS-CAP with 1% protamine 
sulfate concentration.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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0PS-CaP
1PS-CaP
2PS-CaP
4PS-CaP
NIH3T3 24 h
Figure 2 Fluorescence confocal microscopy (20× magnification) of NIH 3T3 and 
293 FT cells transfected with the classical calcium phosphate particle (0PS-CaP) and 
1PS-CaP, 2PS-CaP, and 4PS-CaP. 
Abbreviations:  PS-CaP,  protamine  sulfate  coated-calcium  phosphate;  0PS-CaP,   
PS-CAP  with  0%  protamine  sulfate  concentration;  1PS-CaP,  PS-CAP  with  1% 
protamine  sulfate  concentration;  2PS-Cap,  PS-CaP  with  2%  protamine  sulfate 
concentration; 4PS-CaP, PS-CAP with 4% protamine sulfate concentration.
0PS-CaP
1PS-CaP
2PS-CaP
4PS-CaP
293 FT 24 h
0PS-CaP
1PS-CaP
2PS-CaP
4PS-CaP
HEK 293 2 h 24 h
Figure 3 Fluorescence confocal microscopy (magnification 20× in all cases) of HEK 
293 cells that were transfected with the classical calcium phosphate particle (0PS-
CaP) and 1PS-CaP, 2PS-CaP, and 4PS-CaP, after standing for two hours and for 
seven days. 
Abbreviations:  PS-CaP,  protamine  sulfate-coated  calcium  phosphate;  0PS-CaP,   
PS-CAP  with  0%  protamine  sulfate  concentration;  1PS-CaP,  PS-CAP  with  1% 
protamine  sulfate  concentration;  2PS-Cap,  PS-CaP  with  2%  protamine  sulfate 
concentration; 4PS-CaP, PS-CAP with 4% protamine sulfate concentration.
0PS-CaP
1PS-CaP
2PS-CaP
4PS-CaP
HEK 293 7 days 24 hInternational Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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particles grow with time, and, accordingly, their transfection 
efficiency decreases.1 Many efforts have been made to 
prepare stabilized calcium phosphate nanoparticles to 
improve their transfection reproducibility and efficiency 
by surface-functionalized modification.9,21,22 For example, 
remarkably high transgenic expression in mammalian cells 
has been achieved by the transfection of DNA/calcium 
phosphate particle nanohybrids modified with extracellular 
matrix proteins (either collagen 1 or fibronectin).18
Cationic cell-penetrating peptides have been shown to 
deliver a wide variety of cargo into primary cells and most 
tissues in preclinical models.19 Protamine sulfate is a 5 kDa 
cationic peptide rich in arginine residues that is similar to 
Capps.20 In the present study, considering that the protamine 
sulfate-coated surface of the DNA/calcium phosphate 
particles may stabilize their size and inhibit their further 
growth, we developed a PS-CaP nanoparticle formulation 
for efficient delivery of DNA into cells.
Surface charges and the steric effect of surface 
functionalization of the shell layer that circumvents the 
inorganic nanoparticle core play important roles in regulating 
particle size and colloidal stability, and therefore affect 
transfection efficiency.7,21 In the present study, the steric effect 
of the adsorption of protamine sulfate onto the surface of the 
DNA/calcium phosphate particles may play an important 
role in stabilizing their primary sizes and inhibiting their 
further growth. This effect is due to the possible existence of 
an optimum zeta potential for the adhesive interactions with 
cell membranes, which drives the nanoparticles to approach 
the cell surface and promote colloidal particle stability by 
electrostatic interaction.21,23 This zeta potential is generally close 
to 20–30 mV . However, the zeta potential of the PS-CaP used 
in the study is approximately 13.2 mV , ie, slightly higher than 
that of the 0PS-CaP (about 9.5 mV). Moreover, both values 
are lower than the optimum zeta potential. Thus, the primary 
size of the PS-CaP was much smaller than that of the 0PS-CaP, 
possibly because of the steric effect derived from the protamine 
sulfate-coated surface of the DNA/calcium phosphate particles. 
This steric effect also simultaneously inhibits their further 
growth, thereby enhancing their storage stability.
Smaller nanoparticles favor delivery of DNA to cells 
through endocytosis and accordingly improve transfection 
reproducibility and efficiency.9 Atomic force microscopic 
imaging shows that the PS-CaP were much smaller than the 
0PS-CaP particle (Figure 1). As shown in Figures 2 and 3, 
as well as in the Table, the transfection efficiency of PS-CaP 
was clearly higher than with the classical calcium phosphate 
method in 293 FT, HEK 293, and NIH 3T3 cells. This differ-
ence implies that smaller nanoparticles may promote delivery 
of DNA into cells through endocytosis, and could improve 
the transfection efficiency. In addition, Figure 3 shows that 
PS-CaP could be used for transfection after one week of stor-
age at 4°C with less efficiency loss, indicating that protamine 
sulfate may increase the storage stability of calcium phos-
phate nanoparticles.
Calcium phosphate is the most important inorganic 
constituent of biological hard tissues in living organisms.21 
Calcium phosphate coprecipitated with DNA has become 
one of the most commonly used nonviral vectors since it was 
initially introduced by Graham and van der Eb.2 Its excellent 
biocompatibility is very important for gene delivery, and 
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Figure 4 Effect of PS-CaP and classical calcium phosphate particle (0PS-CaP) dosage 
on cell viability. A series of different doses (0–2 times that of transfection dosage) of 
the 0PS-CaP and 1PS-CaP, 2PS-CaP, and 4PS-CaP were used to treat HEK 293 cells, 
and their inhibitory effect on cell proliferation was evaluated by measuring MTT 
absorption. 
Note: *Indicates that 1PS-CaP is significantly different from 0PS-CaP (P , 0.05). 
Abbreviations: PS-CaP, protamine sulfate-coated calcium phosphate; 0PS-CaP, PS-
CAP with 0% protamine sulfate concentration; 1PS-CaP, PS-CAP with 1% protamine 
sulfate concentration; 2PS-Cap, PS-CaP with 2% protamine sulfate concentration; 
4PS-CaP, PS-CAP with 4% protamine sulfate concentration.
Table 1 results of all transfection experiments
Cell type Storage time Transfection efficiency (%)*
0PS-CaP 1PS-CaP 2PS-CaP 4PS-CaP
heK 293 2 hours 2.64 3.57 6.15 8.33
7 days 1.08 1.94 3.64 4.94
293 FT 20 minutes 3.98 15.56 22.81 49.43
NIh 3T3 20 minutes 0.75 1.97 3.81 4.71
Note: *Transfection efficiency was computed by calibration of blank value from the result of flow cytometry analysis.International Journal of Nanomedicine
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therefore its cytotoxicity has to be evaluated. The cell viability 
inhibition assay indicated that PS-CaP have low cell toxicity, 
similar to 0PS-CaP (Figure 4). In conclusion, PS-CaP are better 
nonviral transfection vectors than the 0PS-CaP vector.
Conclusion
We have developed a novel PS-CaP nanoparticle formulation 
for the delivery of DNA into cells. Protamine sulfate was 
shown to stabilize the size of DNA/calcium phosphate particles, 
inhibit their further growth, and promote endocytic delivery 
of DNA into cells, thereby improving transfection efficiency. 
Furthermore, PS-CaP have low cell toxicity, similar to 
0PS-CaP. Therefore, PS-CaP may be used as a better nonviral 
transfection vector compared with the 0PS-CaP vector.
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